Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
Antitrichomonal Agent, Flagyl® Approval for Additional Indication for Amoebic Dysentery, Giardiasis, Anaerobic Infection and Infectious Enteritis Osaka, Japan, August 10, Shionogi & Co., Ltd. (Head Office: Osaka;
Add to Reading List
Document Date: 2014-11-03 11:26:25
Open Document
File Size: 23,00 KB
Share Result on Facebook
City
Osaka /
/
Company
Shionogi & Co. Ltd. /
Corporate Communications Department Shionogi & Co. Ltd. /
/
Country
Japan /
/
Event
FDA Phase /
/
/
IndustryTerm
foreign healthcare reforms /
with respect to product /
/
MedicalCondition
Amoebic Dysentery /
Giardiasis /
infectious enteritis /
Anaerobic Infection /
/
Organization
Pharmaceutical Affairs and Food Sanitation Council /
Second Committee on New Drugs of the Pharmaceutical Affairs /
Ministry of Health /
Investigational Committee for the Unapproved Drugs and Off-label Drug Use /
/
Person
Isao Teshirogi /
/
/
Position
President & CEO /
/
Product
Flagyl /
metronidazole /
Off-label Drug /
Flagyl® tablet /
/
SocialTag
Infectious diseases
Diarrhea
Waterborne diseases
Giardiasis
Shionogi
Dysentery
Amoebic dysentery
Metronidazole
Trichomoniasis
Medicine
Antitrichomonal Agent, Flagyl® Approval for Additional Indication for Amoebic Dysentery, Giardiasis, Anaerobic Infection and Infectious Enteritis Osaka, Japan, August 10, Shionogi & Co., Ltd. (Head Office: Osaka;